AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20823239 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei
Number of subjects: 0
Study 20823239 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus
Number of subjects: 0
Study 20823239 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 18059502 — intervention group
Group type: EXPERIMENTAL
Intervention: sildenafil 50 mg
Number of subjects: 12
Study 18059502 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 16825049 — intervention group
Group type: EXPERIMENTAL
Intervention: Morselized rib graft (Group A)
Number of subjects: 15
Study 16825049 — intervention group
Group type: COMPARATOR
Intervention: Titanium interbody cages (Group B)
Number of subjects: 15
Study 12707659 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir and hydrocortisone
Number of subjects: 60
Study 12707659 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone alone
Number of subjects: 60
Study 11134566 — intervention group
Group type: EXPERIMENTAL
Intervention: K(+)‐adsorption filter
Number of subjects: 102
Study 11134566 — intervention group
Group type: COMPARATOR
Intervention: Control group (no filter)
Number of subjects: 102
Study 11134566 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 8971288 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent ranitidine 150 mg
Number of subjects: 15
Study 8971288 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent ranitidine 300 mg
Number of subjects: 15
Study 8971288 — intervention group
Group type: COMPARATOR
Intervention: Standard ranitidine 150 mg
Number of subjects: 15
Study 8971288 — intervention group
Group type: COMPARATOR
Intervention: Standard ranitidine 300 mg
Number of subjects: 15
Study 1467076 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% hypertonic saline (HS)
Number of subjects: 30
Study 1467076 — intervention group
Group type: COMPARATOR
Intervention: isotonic saline (NS)
Number of subjects: 30
Study 1467076 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate (RL)
Number of subjects: 30
Study 6360571 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (CPAP) applied and adjusted from 4 cm H2O to a level that obliterated snoring.
Number of subjects: 9
Study 6360571 — intervention group
Group type: COMPARATOR
Intervention: Control night (no CPAP treatment).
Number of subjects: 9
Study 6360571 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP (range 4 to 13 cm H2O).
Number of subjects: 9
Study 31746501 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire-based survey
Number of subjects: 165
Study 31746501 — intervention group
Group type: EXPERIMENTAL
Intervention: Mystery client survey
Number of subjects: 165
Study 31746501 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both surveys
Number of subjects: 165
Study 28744557 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (PMS) for 8 weeks (twice/week)
Number of subjects: 120
Study 28744557 — intervention group
Group type: COMPARATOR
Intervention: Sham pulsed magnetic stimulation for 8 weeks (twice/week)
Number of subjects: 120
Study 28744557 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham)
Number of subjects: 120
Study 26070435 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided impression with Lava C.O.S. (CAI)
Number of subjects: 25
Study 26070435 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyether impression with Impregum pent soft (CI)
Number of subjects: 25
Study 26070435 — intervention group
Group type: EXPERIMENTAL
Intervention: CAI
Number of subjects: 25
Study 26070435 — intervention group
Group type: COMPARATOR
Intervention: CI
Number of subjects: 25
Study 25079861 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestilan 3 - 12 g/day
Number of subjects: 0
Study 25079861 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 - 40 mg/day
Number of subjects: 0
Study 25079861 — intervention group
Group type: COMPARATOR
Intervention: Colestilan
Number of subjects: 0
Study 25079861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22271472 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin with thoracic radiation (PC)
Number of subjects: 546
Study 22271472 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin with thoracic radiation plus thalidomide (TPC)
Number of subjects: 546
Study 20190064 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine case management
Number of subjects: 1665
Study 20190064 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1665
Study 17919359 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative use of thiazolidinediones (TZDs)
Number of subjects: 184
Study 17919359 — intervention group
Group type: COMPARATOR
Intervention: No preoperative use of thiazolidinediones (TZDs)
Number of subjects: 184
Study 15863540 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative vaginal preparation with povidone-iodine
Number of subjects: 308
Study 15863540 — intervention group
Group type: COMPARATOR
Intervention: Standard abdominal scrub alone (Control)
Number of subjects: 308
Study 11967501 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate 40 mg 4 hours or 10 hours before the operation
Number of subjects: 0
Study 11967501 — intervention group
Group type: COMPARATOR
Intervention: Control (no preoperative treatment)
Number of subjects: 0
Study 11967501 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate 40 mg
Number of subjects: 0
Study 9847262 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-breath diffusing capacity for carbon monoxide (DL(CO)) test
Number of subjects: 1275
Study 7715343 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 261
Study 7715343 — intervention group
Group type: COMPARATOR
Intervention: Chronic HBsAg carriers
Number of subjects: 261
Study 2757664 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid sustained release formulation (Contrheuma retard) 300 mg initial dose and 350 mg retard formulation
Number of subjects: 6
Study 2757664 — intervention group
Group type: COMPARATOR
Intervention: Standard ASA solution for intravenous administration
Number of subjects: 6
Study 2757664 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid sustained release formulation (Contrheuma retard)
Number of subjects: 6
Study 2757664 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both formulations
Number of subjects: 6
Study 2757664 — intervention group
Group type: COMPARATOR
Intervention: Comparison of mean time for SA
Number of subjects: 6
Study 337694 — intervention group
Group type: EXPERIMENTAL
Intervention: Novocain treatment (2% procain 5ml, intramuscular injections, 3 times a week, 12 injections a month)
Number of subjects: 173
Study 337694 — intervention group
Group type: EXPERIMENTAL
Intervention: Gerovital H3 treatment according to A. Aslan's method
Number of subjects: 173
Study 337694 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 173
Study 7030048 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% sucrose diet
Number of subjects: 24
Study 7030048 — intervention group
Group type: EXPERIMENTAL
Intervention: 33% sucrose diet
Number of subjects: 24
Study 7030048 — intervention group
Group type: COMPARATOR
Intervention: 5% sucrose diet
Number of subjects: 24
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous training
Number of subjects: 167
Study 30755016 — intervention group
Group type: COMPARATOR
Intervention: Exercise non-responders (defined as change in peak oxygen uptake <1 ml/kg/min)
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: History of elective percutaneous coronary intervention
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline peak oxygen uptake
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intensity
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline physical activity
Number of subjects: 167
Study 30755016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen uptake efficiency slope
Number of subjects: 167
Study 28929527 — intervention group
Group type: EXPERIMENTAL
Intervention: Music exposure during the first six hours of a 12-hour observation period
Number of subjects: 30
Study 28929527 — intervention group
Group type: EXPERIMENTAL
Intervention: Music exposure during the last six hours of a 12-hour observation period
Number of subjects: 30
Study 28929527 — intervention group
Group type: COMPARATOR
Intervention: Control (no music exposure)
Number of subjects: 30
Study 26770664 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg) given 30 minutes prior to weekly group social skills training for 10 weeks
Number of subjects: 0
Study 26770664 — intervention group
Group type: COMPARATOR
Intervention: Placebo given 30 minutes prior to weekly group social skills training for 10 weeks
Number of subjects: 0
Study 26770664 — intervention group
Group type: EXPERIMENTAL
Intervention: Both D-cycloserine and placebo (entire group)
Number of subjects: 0
Study 25132784 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-L sulfa-free polyethylene glycol (4-L SF-PEG)
Number of subjects: 206
Study 25132784 — intervention group
Group type: COMPARATOR
Intervention: 2-L polyethylene glycol solution with ascorbic acid (2-L PEG + Asc)
Number of subjects: 206
Study 22556186 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health record (PHR)‐linked medications module
Number of subjects: 541
Study 22556186 — intervention group
Group type: COMPARATOR
Intervention: Control group with a different PHR‐linked intervention
Number of subjects: 541
Study 19173689 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg
Number of subjects: 90
Study 19173689 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 25 microg
Number of subjects: 90
Study 19173689 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) 0.9% sodium chloride
Number of subjects: 90
Study 17253995 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial body-weight-supported treadmill training (PBWSTT), conducted twice a week for 6 weeks
Number of subjects: 14
Study 16022849 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg (3 courses) with condoms
Number of subjects: 2000
Study 16022849 — intervention group
Group type: COMPARATOR
Intervention: Condoms only (Control)
Number of subjects: 2000
Study 12372311 — intervention group
Group type: EXPERIMENTAL
Intervention: Deloading tape
Number of subjects: 24
Study 12372311 — intervention group
Group type: COMPARATOR
Intervention: Placebo sham tape
Number of subjects: 24
Study 12372311 — intervention group
Group type: COMPARATOR
Intervention: No-tape control
Number of subjects: 24
Study 9832286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2 g intravenously every 12 h)
Number of subjects: 40
Study 9832286 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g intravenously every 8 h)
Number of subjects: 40
Study 7858479 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (10 mg/day)
Number of subjects: 32
Study 7858479 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 32
Study 7858479 — intervention group
Group type: COMPARATOR
Intervention: Patients with adenomas
Number of subjects: 32
Study 2627107 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpress osmotic tablet (prazosin)
Number of subjects: 48
Study 2627107 — intervention group
Group type: COMPARATOR
Intervention: Standard prazosin
Number of subjects: 48
Study 825744 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium in combination with vitamin D2 (calciferol), given orally
Number of subjects: 12
Study 825744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30808203 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention (brief advice and referral to a six-month telephone-based coaching service)
Number of subjects: 280
Study 28012663 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs)
Number of subjects: 60
Study 28012663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25645164 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-augmented One-Session Treatment (A-OST)
Number of subjects: 97
Study 25645164 — intervention group
Group type: COMPARATOR
Intervention: Child-focused One-Session Treatment (OST)
Number of subjects: 97
Study 24423417 — intervention group
Group type: EXPERIMENTAL
Intervention: 68.8 mg lidocaine with 50 μg epinephrine plus 0.9 M mannitol (5 mL formulation)
Number of subjects: 40
Study 24423417 — intervention group
Group type: COMPARATOR
Intervention: 68.8 mg lidocaine with 50 μg epinephrine (1.72 mL formulation)
Number of subjects: 40
Study 22233822 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MC) at 10 or 20 mg/m² every 3 weeks
Number of subjects: 38
Study 19299753 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week dragon boat physical activity intervention
Number of subjects: 8
Study 17879121 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation including genetic information
Number of subjects: 294
Study 17879121 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation not including genetic information
Number of subjects: 294
Study 17879121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no consultation)
Number of subjects: 294
Study 15586886 — intervention group
Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay with low dose-rate (LDR) irradiation (4 mGy/min)
Number of subjects: 0
Study 15586886 — intervention group
Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay with high dose-rate (HDR) irradiation (1 Gy/min)
Number of subjects: 0
Study 15586886 — intervention group
Group type: COMPARATOR
Intervention: G2 assay with 0.4 Gy 60Co gamma rays
Number of subjects: 0
Study 15586886 — intervention group
Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay
Number of subjects: 0
Study 15586886 — intervention group
Group type: COMPARATOR
Intervention: Dose-rate sparing index
Number of subjects: 0
Study 11189924 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 48
Study 11189924 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 48
Study 9185430 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 202
Study 9185430 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release oral morphine
Number of subjects: 202
Study 1489037 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac (intramuscular)
Number of subjects: 50
Study 1489037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 3930688 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposyn at 0.34 g
Number of subjects: 0
Study 3930688 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposyn at 0.68 g
Number of subjects: 0
Study 3930688 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Liposyn at 0.68 g/kg/day
Number of subjects: 0
Study 3930688 — intervention group
Group type: COMPARATOR
Intervention: Reference group (fat-free parenteral nutrition)
Number of subjects: 0
Study 28292339 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric sulfate with mineral trioxide aggregate (FS+MTA) pulpotomy
Number of subjects: 70
Study 28292339 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 70
Study 25884981 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose: 50 mg Zn, 75 mcg Se, 250 IU vitamin E
Number of subjects: 150
Study 25884981 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose: 25 mg Zn, 50 mcg Se, 250 IU vitamin E
Number of subjects: 150
Study 25884981 — intervention group
Group type: COMPARATOR
Intervention: Standard supplement (control)
Number of subjects: 150
Study 23720186 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking-related cues (smoking images in study 1; cigarette cue-exposure task in study 2)
Number of subjects: 51
Study 23720186 — intervention group
Group type: COMPARATOR
Intervention: Neutral cues (neutral images in study 1; drinking-straw task in study 2)
Number of subjects: 51
Study 22080020 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/kg PFA
Number of subjects: 528
Study 22080020 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg/kg PFA
Number of subjects: 528
Study 22080020 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,500 mg/kg PFA
Number of subjects: 528
Study 22080020 — intervention group
Group type: COMPARATOR
Intervention: Control diet without PFA
Number of subjects: 528
Study 18645554 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetry monitoring during laparoscopic cholecystectomy
Number of subjects: 21
Study 16563323 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg/kg
Number of subjects: 60
Study 16563323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12556604 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral group psychotherapy alone (N=103)
Number of subjects: 199
Study 12556604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group psychotherapy supplemented by clinical case management (N=96)
Number of subjects: 199
Study 10680104 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 2.5 +/- 1.0 mg/kg
Number of subjects: 40
Study 10680104 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1.6 +/- 0.6 mg/kg
Number of subjects: 40
Study 10680104 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40
Study 10680104 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study 10680104 — intervention group
Group type: COMPARATOR
Intervention: Thiopental and Propofol
Number of subjects: 40
Study 9102587 — intervention group
Group type: EXPERIMENTAL
Intervention: Trachlight intubation
Number of subjects: 66
Study 9102587 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 66
Study 1712323 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone, 25 mg five times at 12-hour intervals (n = 192)
Number of subjects: 385
Study 1712323 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone, 600 mg as a single dose (n = 193)
Number of subjects: 385
Study 6179101 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (100 mg i.v.)
Number of subjects: 20
Study 6179101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31673775 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance after ASCT
Number of subjects: 80
Study 29092713 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Family Nurse Partnership (gFNP)
Number of subjects: 166
Study 29092713 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 166
Study 27513257 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus ketamine (Group K)
Number of subjects: 90
Study 27513257 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine (Group L)
Number of subjects: 90
Study 27513257 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline solution with epinephrine (Group S)
Number of subjects: 90
Study 25167690 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles' (powdered formulation of iron, vitamins A and C, folic acid, and zinc)
Number of subjects: 621
Study 25167690 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles'
Number of subjects: 621
Study 25167690 — intervention group
Group type: COMPARATOR
Intervention: Control (liquid iron and vitamins A and D)
Number of subjects: 621
Study 25167690 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles' and Control
Number of subjects: 621
Study 22297671 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy volunteers
Number of subjects: 19
Study 22297671 — intervention group
Group type: COMPARATOR
Intervention: Uric acid stone formers
Number of subjects: 19
Study 20642549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 100 mg twice daily
Number of subjects: 48
Study 20642549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 300 mg once daily
Number of subjects: 48
Study 20642549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 50-600 mg once daily
Number of subjects: 48
Study 20642549 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 48
Study 18095612 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic Acarbose capsule (DAC)
Number of subjects: 179
Study 18095612 — intervention group
Group type: COMPARATOR
Intervention: Glucoby
Number of subjects: 179
Study 15735805 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (Aspirin, Clopidogrel, Dipyridamole - ACD)
Number of subjects: 22
Study 15735805 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Aspirin and Clopidogrel (AC)
Number of subjects: 22
Study 15735805 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin, Clopidogrel, Dipyridamole (ACD)
Number of subjects: 22
Study 11850324 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based tutorials only (Computer)
Number of subjects: 32
Study 11850324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lectures supplemented with Web-based tutorials (Both)
Number of subjects: 32
Study 11850324 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture format (Lecture)
Number of subjects: 32
Study 11850324 — intervention group
Group type: EXPERIMENTAL
Intervention: All formats (Computer, Both, Lecture)
Number of subjects: 32
Study 9851729 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIg) in patients with DM
Number of subjects: 0
Study 9851729 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIg) in patients with IBM
Number of subjects: 0
Study 9851729 — intervention group
Group type: COMPARATOR
Intervention: High-dose intravenous immunoglobulin (IVIg) in specific muscle groups in IBM patients
Number of subjects: 0